At a glance
- Originator Novartis
- Class Phosphonic acids; Tetrazoles
- Mechanism of Action Endopeptidase inhibitors; Endothelin-converting enzyme 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 22 May 2001 No-Development-Reported for Hypertension in USA (Unknown route)
- 27 Nov 1997 New profile
- 27 Nov 1997 Preclinical development for Hypertension in USA (Unknown route)